首页> 外文期刊>ACS applied materials & interfaces >Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents
【24h】

Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents

机译:纳米芬顿反应器作为一类新型的氧化应激放大抗癌治疗剂

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer cells, compared to normal cells, are under oxidative stress associated with an elevated level of reactive oxygen species (ROS) and are more vulnerable to oxidative stress induced by ROS generating agents. Thus, manipulation of the ROS level provides a logical approach to kill cancer cells preferentially, without significant toxicity to normal cells, and great efforts have been dedicated to the development of strategies to induce cytotoxic oxidative stress for cancer treatment. Fenton reaction is an important biological reaction in which irons convert hydrogen peroxide (H2O2) to highly toxic hydroxyl radicals that escalate ROS stress. Here, we report Fenton reaction-performing polymer (PolyCAFe) micelles as a new class of ROS-manipulating anticancer therapeutic agents. Amphiphilic PolyCAFe incorporates H2O2-generating benzoyloxycinnamaldehyde and iron-containing compounds in its backbone and self-assembles to form micelles that serve as Nano-Fenton reactors to generate cytotoxic hydroxyl radicals, killing cancer cells preferentially. When intravenously injected, PolyCAFe micelles could accumulate in tumors preferentially to remarkably suppress tumor growth, without toxicity to normal tissues. This study demonstrates the tremendous translatable potential of Nano-Fenton reactors as a new class of anticancer drugs.
机译:与正常细胞相比,癌细胞处于与高水平的活性氧(ROS)相关的氧化应激状态,并且更容易受到ROS产生剂诱导的氧化应激的影响。因此,对ROS水平的控制提供了一种优先杀死癌细胞的逻辑方法,而对正常细胞没有明显的毒性,并且已经致力于开发诱导细胞毒性氧化应激的策略来治疗癌症。 Fenton反应是一种重要的生物反应,其中铁将过氧化氢(H2O2)转化为剧毒的羟基自由基,从而加剧ROS压力。在这里,我们报告Fenton反应执行聚合物(PolyCAFe)胶束作为一类新的ROS操纵抗癌治疗剂。两亲性的PolyCAFe在其骨架中结合了生成H2O2的苯甲酰氧基肉桂醛和含铁化合物,并自组装形成胶束,该胶束用作纳米芬顿反应器,产生细胞毒性羟基自由基,优先杀死癌细胞。静脉注射时,PolyCAFe胶束可以优先在肿瘤中蓄积,从而显着抑制肿瘤的生长,而对正常组织没有毒性。这项研究证明了纳米芬顿反应器作为一种新型的抗癌药物具有巨大的翻译潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号